Abonnement à la biblothèque: Guest
Critical Reviews™ in Neurobiology

Publication de 3  numéros par an

ISSN Imprimer: 0892-0915

ISSN En ligne: 2375-0014

SJR: 0.121

Brain-Derived Neurotrophic Factor Activation of TrkB Protects Neurons from HIV-1/gp120-Induced Cell Death

Volume 16, Numéro 1&2, 2004, pp. 51-58
DOI: 10.1615/CritRevNeurobiol.v16.i12.50
Get accessGet access

RÉSUMÉ

Patients with the human immunodeficiency virus type 1 (HIV-1) develop in the late phase of infection a complex of neurological signs termed Acquired Immune Deficiency Syndrome-Related Dementia (ADC). These patients exhibit cortical and subcortical atrophy. Considerable experimental data indicate that the HIV-1 envelope glycoprotein gp120 may be one of the agents causing neuronal cell death. Gp120 causes neuronal cell death both in vitro and in vivo by activating a caspase-dependent apoptotic pathway, and in particular caspase-3. The neurotrophin brain-derived neurotrophic factor (BDNF) has been shown to prevent gp120-mediated apoptosis of cerebellar granule cells by inhibiting caspase-3 activation. However, the signal transduction pathway that contributes to the neuroprotective effects of BDNF has not been determined. BDNF binds with high affinity to the tyrosine kinase receptor TrkB and activates different intracellular signaling cascade including the extracellular signal-related kinases (ERK) and the phosphatidylinositol 3-kinase (PI3-K). Pharmacological inhibition of TrkB or ERK1/2, but not PI3-K, greatly reduced the ability of BDNF to block gp120-mediated apoptosis of cerebellar granule cells. These findings suggest that TrkB-mediated activation of ERK1/2 is the main signaling pathway that contributes to neuroprotection against gp120.

CITÉ PAR
  1. Nosheny Rachel L., Ahmed Farid, Yakovlev Alexander, Meyer Edwin M., Ren Ke, Tessarollo Lino, Mocchetti Italo, Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo, European Journal of Neuroscience, 25, 8, 2007. Crossref

  2. Ellis Ronald, Langford Dianne, Masliah Eliezer, HIV and antiretroviral therapy in the brain: neuronal injury and repair, Nature Reviews Neuroscience, 8, 1, 2007. Crossref

  3. Mocchetti Italo, Bachis Alessia, Masliah Eliezer, Chemokine receptors and neurotrophic factors: Potential therapy against aids dementia?, Journal of Neuroscience Research, 86, 2, 2008. Crossref

  4. BACHIS ALESSIA, MOCCHETTI ITALO, Brain-Derived Neurotrophic Factor Is Neuroprotective against Human Immunodeficiency Virus-1 Envelope Proteins, Annals of the New York Academy of Sciences, 1053, 1, 2008. Crossref

  5. Sui Ziye, Sniderhan Lynn F., Fan Shongshan, Kazmierczak Katarzyna, Reisinger Elizabeth, Kovács Attila D., Potash Mary Jane, Dewhurst Stephen, Gelbard Harris A., Maggirwar Sanjay B., Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3β to antagonize nuclear factor-κB survival pathway in neurons, European Journal of Neuroscience, 23, 10, 2006. Crossref

  6. Bachis Alessia, Mocchetti Italo, Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis, Journal of Neuroscience Research, 83, 5, 2006. Crossref

  7. Li W., Galey D., Mattson Mark P., Nath Avindra, Molecular and cellular mechanisms of neuronal cell death in HIV dementia, Neurotoxicity Research, 8, 1-2, 2005. Crossref

  8. Nosheny Rachel L., Mocchetti Italo, Bachis Alessia, Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration, Neurotoxicity Research, 8, 1-2, 2005. Crossref

  9. Leyhe T., Stransky Elke, Eschweiler G. W., Buchkremer G., Laske C., Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease, European Archives of Psychiatry and Clinical Neuroscience, 258, 2, 2008. Crossref

  10. Meeker Rick B., Poulton Winona, Markovic-Plese Silva, Hall Colin, Robertson Kevin, Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection, Journal of NeuroVirology, 17, 3, 2011. Crossref

  11. Gelbard Harris A., Dewhurst Stephen, Maggirwar Sanjay B., Kiebala Michelle, Polesskaya Oksana, Gendelman Howard E., Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: A therapeutic strategy based on modulation of mixed lineage kinase, Neurotherapeutics, 7, 4, 2010. Crossref

  12. Avdoshina Valeriya, Becker Jody, Campbell Lee A., Parsadanian Maia, Mhyre Timothy, Tessarollo Lino, Mocchetti Italo, Neurotrophins modulate the expression of chemokine receptors in the brain, Journal of NeuroVirology, 17, 1, 2011. Crossref

  13. Laske Christoph, Stransky Elke, Leyhe Thomas, Eschweiler Gerhard W., Maetzler Walter, Wittorf Andreas, Soekadar Surjo, Richartz Elke, Koehler Niklas, Bartels Mathias, Buchkremer Gerhard, Schott Klaus, BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls, Journal of Psychiatric Research, 41, 5, 2007. Crossref

  14. Kim Dong-Sub, Ahn Soon-Cheol, Kim Young-Jin, Park Byoung-Keun, Ahn Yong-Tae, Kim Ji-Youn, Kyoji Morita, Her Song, Glucocorticoid Regulation of Gene Expression in Hippocampal CA3 and Dentate Gyrus, Journal of Life Science, 17, 3, 2007. Crossref

  15. Ahmed Farid, Tessarollo Lino, Thiele Carol, Mocchetti Italo, Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain, Brain Research, 1227, 2008. Crossref

  16. Yan Qing-Shan, Feng Mei-Jinag, Yan Shu-E, RNA interference-mediated inhibition of brain-derived neurotrophic factor expression increases cocaine's cytotoxicity in cultured cells, Neuroscience Letters, 414, 2, 2007. Crossref

  17. Biber Knut, Boddeke Hendrikus W. G. M., Chemokines and Their Receptors in Central Nervous System Disease, in Chemokine Receptors as Drug Targets, 2011. Crossref

  18. Meeker Rick B., Poulton Winona, Feng Wen-hai, Hudson Lola, Longo Frank M., Suppression of Immunodeficiency Virus-Associated Neural Damage by the p75 Neurotrophin Receptor Ligand, LM11A-31, in an In Vitro Feline Model, Journal of Neuroimmune Pharmacology, 7, 2, 2012. Crossref

  19. Allegretti Marcello, Cesta Maria Candida, Garin Alexandre, Proudfoot Amanda E.I., Current status of chemokine receptor inhibitors in development, Immunology Letters, 145, 1-2, 2012. Crossref

  20. Maratou Klio, Wallace Victoria C.J., Hasnie Fauzia S., Okuse Kenji, Hosseini Ramine, Jina Nipurna, Blackbeard Julie, Pheby Timothy, Orengo Christine, Dickenson Anthony H., McMahon Stephen B., Rice Andrew S.C., Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain, European Journal of Pain, 13, 4, 2009. Crossref

  21. Mocchetti Italo, Bachis Alessia, Campbell Lee A., Avdoshina Valeriya, Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors, Journal of Neuroimmune Pharmacology, 9, 2, 2014. Crossref

  22. Fields Jerel, Dumaop Wilmar, Langford T. D., Rockenstein Edward, Masliah E., Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders, Journal of Neuroimmune Pharmacology, 9, 2, 2014. Crossref

  23. Steiner Joseph P., Nath Avindra, Neurotrophin Strategies for Neuroprotection: Are They Sufficient?, Journal of Neuroimmune Pharmacology, 9, 2, 2014. Crossref

  24. Bushell Trevor, The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders, The Journal of Physiology, 581, 1, 2007. Crossref

  25. Williams Kimberly S., Killebrew Deirdre A., Clary Gillian P., Meeker Rick B., Opposing Effects of NGF and proNGF on HIV Induced Macrophage Activation, Journal of Neuroimmune Pharmacology, 11, 1, 2016. Crossref

  26. Meeker Rick B., Poulton Winona, Clary Gillian, Schriver Michael, Longo Frank M., Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis, Experimental Neurology, 275, 2016. Crossref

  27. Simon Liz, Song Keijing, Vande Stouwe Curtis, Hollenbach Andrew, Amedee Angela, Mohan Mahesh, Winsauer Peter, Molina Patricia, Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques, Journal of Neuroimmune Pharmacology, 11, 1, 2016. Crossref

  28. Periyasamy Palsamy, Guo Ming-Lei, Buch Shilpa, Growth and Neurotrophic Factors in HIV-Associated Neurocognitive Disorders, in Neuroimmune Pharmacology, 2017. Crossref

  29. Tong Jing, Buch Shilpa, Yao Honghong, Wu Chengxiang, Tong Hsin-I, Wang Youwei, Lu Yuanan, Zheng Jialin Charles, Monocytes-Derived Macrophages Mediated Stable Expression of Human Brain-Derived Neurotrophic Factor, a Novel Therapeutic Strategy for NeuroAIDS, PLoS ONE, 9, 2, 2014. Crossref

  30. Grab Dennis J., Garcia-Garcia Jose C., Nikolskaia Olga V., Kim Yuri V., Brown Amanda, Pardo Carlos A., Zhang Yongqing, Becker Kevin G., Wilson Brenda A., de A. Lima Ana Paula C., Scharfstein Julio, Dumler J. Stephen, Raper Jayne, Protease Activated Receptor Signaling Is Required for African Trypanosome Traversal of Human Brain Microvascular Endothelial Cells, PLoS Neglected Tropical Diseases, 3, 7, 2009. Crossref

  31. Rodriguez Hector E., Lakshmi Seetha, Somboonwit Charurut, Oxner Asa, Guerra Lucy, Addisu Anteneh, Gutierrez Louise, Sinnott John T., Nilofer Christina, Kangueane Pandjassarame, Shapshak Paul, Gene Therapy Blueprints for NeuroAIDS, in Global Virology II - HIV and NeuroAIDS, 2017. Crossref

  32. Chang Li-Hsin, Lin Hui-Ching, Huang Shiang-Suo, Chen I-Chih, Chu Kai-Wen, Chih Chun-Lien, Liang Yao-Wen, Lee Yi-Chung, Chen You-Yin, Lee Yi-Hsuan, Lee I-Hui, Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation, Scientific Reports, 8, 1, 2018. Crossref

  33. Wan Li, Ren Liang, Chen Lulan, Wang Guoxiang, Liu Xu, Wang Benjamin H., Wang Yun, M-Calpain Activation Facilitates Seizure Induced KCC2 Down Regulation, Frontiers in Molecular Neuroscience, 11, 2018. Crossref

  34. Manadas Bruno J., Melo Carlos V., Gomes João R., Duarte Carlos B., Neurotrophin Signaling and Cell Survival, in Interaction Between Neurons and Glia in Aging and Disease, 2007. Crossref

  35. Bachis Alessia, Avdoshina Valeriya, Lim Seung T., Mocchetti Italo, Neurotrophic Factors and NeuroAIDS: A Lesson from Brain-Derived Neurotrophic Factor, in Handbook of Neurotoxicity, 2014. Crossref

  36. Marker Daniel F., Lu Shao-Ming, Gelbard Harris A., Human Immunodeficiency Virus, in Microglia in Health and Disease, 2014. Crossref

  37. Vidal-Martinez Guadalupe, Najera Katherine, Miranda Julie D., Gil-Tommee Carolina, Yang Barbara, Vargas-Medrano Javier, Diaz-Pacheco Valeria, Perez Ruth G., FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2 +/− Mice, Neuroscience, 411, 2019. Crossref

  38. Xie Youmie, Seawell Jaimie, Boesch Emily, Allen Lauren, Suchy Ashley, Longo Frank M., Meeker Rick B., Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice, Experimental Neurology, 335, 2021. Crossref

  39. Singh Hina, Ojeda-Juárez Daniel, Maung Ricky, Shah Rohan, Roberts Amanda J., Kaul Marcus, A pivotal role for Interferon-α receptor-1 in neuronal injury induced by HIV-1, Journal of Neuroinflammation, 17, 1, 2020. Crossref

  40. Sénécal Vincent, Barat Corinne, Tremblay Michel J., The delicate balance between neurotoxicity and neuroprotection in the context of HIV ‐1 infection , Glia, 69, 2, 2021. Crossref

  41. Killebrew Deirdre A., Williams Kimberly S., Xie Youmei, Longo Frank, Meeker Rick B., Suppression of HIV-associated Macrophage Activation by a p75 Neurotrophin Receptor Ligand, Journal of Neuroimmune Pharmacology, 2021. Crossref

  42. Fogle Jonathan E., Hudson Lola, Thomson Andrea, Sherman Barbara, Gruen Margaret, Lacelles B. Duncan, Colby Brenda M., Clary Gillian, Longo Frank, Meeker Rick B., Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31, Journal of NeuroVirology, 27, 2, 2021. Crossref

  43. Dhakal Susov, He Li, Lyuboslavsky Polina, Sidhu Curran, Chrenek Micah A., Sellers Jana T., Boatright Jeffrey H., Geisert Eldon E., Setterholm Noah A., McDonald Frank E., Iuvone P. Michael, A Tropomycin-Related Kinase B Receptor Activator for the Management of Ocular Blast-Induced Vision Loss, Journal of Neurotrauma, 38, 20, 2021. Crossref

  44. DA SILVA Daniele Gonçalves, CARVALHO Iracema Luisa Quintino de, TOSCANO Eliana Cristina de Brito, SANTOS Beatriz Álvares da Silva Senra, OLIVEIRA Bruna da Silva, CAMPOS Marco Antônio, FONSECA Flávio Guimarães da , CAMARGOS Quezya Mendes, SOUSA Gabriela Ferreira de, CALIARI Marcelo Vidigal, TEIXEIRA Antônio Lúcio, MIRANDA Aline Silva de, RACHID Milene Alvarenga, Brain-derived neurotrophic factor is down regulated after bovine alpha-herpesvirus 5 infection in both wild-type and TLR3/7/9 deficient mice, Journal of Veterinary Medical Science, 83, 2, 2021. Crossref

  45. Mungmunpuntipantip Rujittika, Wiwanitkit Viroj, Brain-derived neurotrophic factor and its clinical applications, Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain